Detalhe da pesquisa
1.
Quality of Life and Treatment-Related Side Effects in Patients With HR+/HER2- Advanced Breast Cancer: Findings From a Multicountry Survey.
Oncologist
; 28(10): 856-865, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37523663
2.
Final results of RIGHT Choice: Ribociclib plus endocrine therapy vs combination chemotherapy in premenopausal women with clinically aggressive HR+/HER2- advanced breast cancer.
J Clin Oncol
; : JCO2400144, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38771995
3.
Quality-of-life methodology in hormone receptor-positive advanced breast cancer: Current tools and perspectives for the future.
Cancer Treat Rev
; 102: 102321, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34852292